{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T03:41:01Z","timestamp":1780630861414,"version":"3.54.1"},"reference-count":52,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,5,15]],"date-time":"2024-05-15T00:00:00Z","timestamp":1715731200000},"content-version":"vor","delay-in-days":469,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["mp.uscap.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Modern Pathology"],"published-print":{"date-parts":[[2023,2]]},"DOI":"10.1016\/j.modpat.2022.100005","type":"journal-article","created":{"date-parts":[[2023,1,9]],"date-time":"2023-01-09T16:07:10Z","timestamp":1673280430000},"page":"100005","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["What Is the Value of Counting Mast Cells in Gastrointestinal Mucosal Biopsies?"],"prefix":"10.1016","volume":"36","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1121-267X","authenticated-orcid":false,"given":"Nicole C.","family":"Panarelli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason L.","family":"Hornick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rhonda K.","family":"Yantiss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.modpat.2022.100005_bib1","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1016\/j.jaci.2021.06.030","article-title":"Developing a standardized approach for assessing mast cells and eosinophils on tissue biopsies: a Work Group Report of the AAAAI Allergic Skin Diseases Committee","volume":"148","author":"Zimmermann","year":"2021","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.modpat.2022.100005_bib2","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1111\/j.1365-2141.2008.07244.x","article-title":"Advances in the understanding of mast cell function","volume":"142","author":"Heib","year":"2008","journal-title":"Br J Haematol"},{"key":"10.1016\/j.modpat.2022.100005_bib3","first-page":"620","article-title":"Mast cell: a multi-functional master cell","volume":"6","author":"Krystel-Whittemore","year":"2015","journal-title":"Front Immunol"},{"key":"10.1016\/j.modpat.2022.100005_bib4","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1136\/gutjnl-2015-309151","article-title":"The role of mast cells in functional GI disorders","volume":"65","author":"Wouters","year":"2016","journal-title":"Gut"},{"key":"10.1016\/j.modpat.2022.100005_bib5","doi-asserted-by":"crossref","first-page":"2364","DOI":"10.1097\/MIB.0000000000000142","article-title":"The multifaceted mast cell in inflammatory bowel disease","volume":"20","author":"Hamilton","year":"2014","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.modpat.2022.100005_bib6","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1016\/j.jcmgh.2022.02.017","article-title":"Role of macrophages and mast cells as key players in the maintenance of gastrointestinal smooth muscle homeostasis and disease","volume":"13","author":"Mischopoulou","year":"2022","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"10.1016\/j.modpat.2022.100005_bib7","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1159\/000487538","article-title":"The staining of mast cells: a historical overview","volume":"176","author":"Ribatti","year":"2018","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.modpat.2022.100005_bib8","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.iac.2014.01.005","article-title":"Mastocytosis: immunophenotypical features of the transformed mast cells are unique among hematopoietic cells","volume":"34","author":"Horny","year":"2014","journal-title":"Immunol Allergy Clin North Am"},{"key":"10.1016\/j.modpat.2022.100005_bib9","series-title":"WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues","article-title":"Mastocytosis","author":"Horny","year":"2017"},{"key":"10.1016\/j.modpat.2022.100005_bib10","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1080\/1042819021000039965","article-title":"Tryptase a novel biochemical marker of acute myeloid leukemia","volume":"43","author":"Sperr","year":"2002","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.modpat.2022.100005_bib11","first-page":"e9577","article-title":"Tryptase positivity in chronic myeloid leukemia with marked basophilia","volume":"12","author":"Khafateh","year":"2020","journal-title":"Cureus"},{"key":"10.1016\/j.modpat.2022.100005_bib12","doi-asserted-by":"crossref","first-page":"6763","DOI":"10.1007\/s13277-014-1899-8","article-title":"Diagnostic value of CD117 in differential diagnosis of acute leukemias","volume":"35","author":"Ahmadi","year":"2014","journal-title":"Tumour Biol"},{"key":"10.1016\/j.modpat.2022.100005_bib13","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/s00281-009-0165-4","article-title":"Physiological and pathophysiological functions of intestinal mast cells","volume":"31","author":"Bischoff","year":"2009","journal-title":"Semin Immunopathol"},{"key":"10.1016\/j.modpat.2022.100005_bib14","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.1016\/j.jaci.2022.04.020","article-title":"Tyrosine kinase inhibitors for the treatment of indolent systemic mastocytosis: are we there yet?","volume":"149","author":"Akin","year":"2022","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.modpat.2022.100005_bib15","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/S0889-8588(05)70298-7","article-title":"Gastrointestinal abnormalities and involvement in systemic mastocytosis","volume":"14","author":"Jensen","year":"2000","journal-title":"Hematol Oncol Clin North Am"},{"key":"10.1016\/j.modpat.2022.100005_bib16","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1111\/his.13033","article-title":"Clinicopathological characteristics of systemic mastocytosis in the intestine","volume":"69","author":"Shih","year":"2016","journal-title":"Histopathology"},{"key":"10.1016\/j.modpat.2022.100005_bib17","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1097\/PAS.0000000000000190","article-title":"A\u00a0clinicopathologic study of 24 cases of systemic mastocytosis involving the gastrointestinal tract and assessment of mucosal mast cell density in irritable bowel syndrome and asymptomatic patients","volume":"38","author":"Doyle","year":"2014","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.modpat.2022.100005_bib18","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1097\/PAS.0000000000001126","article-title":"Are enterocolic mucosal mast cell aggregates clinically relevant in patients without suspected or established systemic mastocytosis?","volume":"42","author":"Johncilla","year":"2018","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.modpat.2022.100005_bib19","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1159\/000328760","article-title":"Definitions, criteria and global classification of mast cell disorders with special reference to mast cell activation syndromes: a consensus proposal","volume":"157","author":"Valent","year":"2012","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.modpat.2022.100005_bib20","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1016\/j.jaci.2010.02.019","article-title":"Clinical, biological, and molecular characteristics of clonal mast cell disorders presenting with systemic mast cell activation symptoms","volume":"125","author":"Alvarez-Twose","year":"2010","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.modpat.2022.100005_bib21","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.jaci.2011.04.037","article-title":"Mast cell activation syndrome: a newly recognized disorder with systemic clinical manifestations","volume":"128","author":"Hamilton","year":"2011","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.modpat.2022.100005_bib22","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/j.jaci.2021.04.004","article-title":"Small intestinal immunopathology and GI-associated antibody formation in hereditary alpha-tryptasemia","volume":"148","author":"Konnikova","year":"2021","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.modpat.2022.100005_bib23","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1097\/PAS.0000000000001676","article-title":"Distinct small intestine mast cell histologic changes in patients with hereditary alpha-tryptasemia and mast cell activation syndrome","volume":"45","author":"Hamilton","year":"2021","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.modpat.2022.100005_bib24","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/j.jaci.2020.06.035","article-title":"Heritable risk for severe anaphylaxis associated with increased alpha-tryptase-encoding germline copy number at TPSAB1","volume":"147","author":"Lyons","year":"2021","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.modpat.2022.100005_bib25","doi-asserted-by":"crossref","first-page":"17","DOI":"10.14309\/ajg.0000000000001036","article-title":"ACG clinical guideline: management of irritable bowel syndrome","volume":"116","author":"Lacy","year":"2021","journal-title":"Am J Gastroenterol"},{"issue":"6","key":"10.1016\/j.modpat.2022.100005_bib26","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1053\/j.gastro.2016.02.031","article-title":"Bowel disorders","volume":"150","author":"Lacy","year":"2016","journal-title":"Gastroenterology"},{"key":"10.1016\/j.modpat.2022.100005_bib27","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1053\/gast.2002.33579","article-title":"Activation of the mucosal immune system in irritable bowel syndrome","volume":"122","author":"Chadwick","year":"2002","journal-title":"Gastroenterology"},{"key":"10.1016\/j.modpat.2022.100005_bib28","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1111\/j.1365-2036.2007.03370.x","article-title":"Costs of health care for irritable bowel syndrome, chronic constipation, functional diarrhoea and functional abdominal pain","volume":"26","author":"Nyrop","year":"2007","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.modpat.2022.100005_bib29","first-page":"250","article-title":"The emerging role of mast cells in irritable bowel syndrome","volume":"14","author":"Boeckxstaens","year":"2018","journal-title":"Gastroenterol Hepatol (N Y)"},{"key":"10.1016\/j.modpat.2022.100005_bib30","doi-asserted-by":"crossref","first-page":"362","DOI":"10.5858\/2006-130-362-MEIMMC","article-title":"Mastocytic enterocolitis: increased mucosal mast cells in chronic intractable diarrhea","volume":"130","author":"Jakate","year":"2006","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.modpat.2022.100005_bib31","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/950582","article-title":"Allergic mastocytic gastroenteritis and colitis: an unexplained etiology in chronic abdominal pain and gastrointestinal dysmotility","volume":"2012","author":"Akhavein","year":"2012","journal-title":"Gastroenterol Res Pract"},{"key":"10.1016\/j.modpat.2022.100005_bib32","doi-asserted-by":"crossref","DOI":"10.1111\/nmo.13192","article-title":"Colonic immune cells in irritable bowel syndrome: a systematic review and meta-analysis","volume":"30","author":"Bashashati","year":"2018","journal-title":"Neurogastroenterol Motil"},{"key":"10.1016\/j.modpat.2022.100005_bib33","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1007\/s10620-013-2930-4","article-title":"Colonic mucosal immune activity in irritable bowel syndrome: comparison with healthy controls and patients with ulcerative colitis","volume":"59","author":"Ahn","year":"2014","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.modpat.2022.100005_bib34","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1111\/j.1440-1746.2005.04143.x","article-title":"Mucosal mast cell counts correlate with visceral hypersensitivity in patients with diarrhea predominant irritable bowel syndrome","volume":"21","author":"Park","year":"2006","journal-title":"J\u00a0Gastroenterol Hepatol"},{"key":"10.1016\/j.modpat.2022.100005_bib35","doi-asserted-by":"crossref","first-page":"43","DOI":"10.3109\/00365521.2013.857712","article-title":"Mast cell number, substance P and vasoactive intestinal peptide in irritable bowel syndrome with diarrhea","volume":"49","author":"Sohn","year":"2014","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.modpat.2022.100005_bib36","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1172\/JCI29255","article-title":"Role for protease activity in visceral pain in irritable bowel syndrome","volume":"117","author":"Cenac","year":"2007","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.modpat.2022.100005_bib37","doi-asserted-by":"crossref","first-page":"244","DOI":"10.5056\/jnm.2013.19.2.244","article-title":"Mucosal mast cell count is associated with intestinal permeability in patients with diarrhea predominant irritable bowel syndrome","volume":"19","author":"Lee","year":"2013","journal-title":"J\u00a0Neurogastroenterol Motil"},{"key":"10.1016\/j.modpat.2022.100005_bib38","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.3892\/mmr.2013.1320","article-title":"Low-grade inflammation in the rectum of patients with sporadic irritable bowel syndrome","volume":"7","author":"El-Salhy","year":"2013","journal-title":"Mol Med Rep"},{"key":"10.1016\/j.modpat.2022.100005_bib39","doi-asserted-by":"crossref","first-page":"G1053","DOI":"10.1152\/ajpgi.00153.2011","article-title":"SERT and TPH-1 mRNA expression are reduced in irritable bowel syndrome patients regardless of visceral sensitivity state in large intestine","volume":"302","author":"Kerckhoffs","year":"2012","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1016\/j.modpat.2022.100005_bib40","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1177\/2050640617691690","article-title":"Downregulation of mucosal mast cell activation and immune response in diarrhoea-irritable bowel syndrome by oral disodium cromoglycate: a pilot study","volume":"5","author":"Lobo","year":"2017","journal-title":"United European Gastroenterol J"},{"key":"10.1016\/j.modpat.2022.100005_bib41","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1136\/gut.2010.213108","article-title":"The mast cell stabiliser ketotifen decreases visceral hypersensitivity and improves intestinal symptoms in patients with irritable bowel syndrome","volume":"59","author":"Klooker","year":"2010","journal-title":"Gut"},{"key":"10.1016\/j.modpat.2022.100005_bib42","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1111\/j.1365-2036.2009.04041.x","article-title":"Effect of mesalazine on mucosal immune biomarkers in irritable bowel syndrome: a randomized controlled proof-of-concept study","volume":"30","author":"Corinaldesi","year":"2009","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.modpat.2022.100005_bib43","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1136\/gutjnl-2014-308188","article-title":"Randomised controlled trial of mesalazine in IBS","volume":"65","author":"Barbara","year":"2016","journal-title":"Gut"},{"key":"10.1016\/j.modpat.2022.100005_bib44","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.685865","article-title":"Responses of mast cells to pathogens: beneficial and detrimental roles","volume":"12","author":"Jim\u00e9nez","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.modpat.2022.100005_bib45","doi-asserted-by":"crossref","first-page":"224","DOI":"10.14309\/ajg.0000000000000474","article-title":"Mast cell infiltration is associated with persistent symptoms and endoscopic abnormalities despite resolution of eosinophilia in pediatric eosinophilic esophagitis","volume":"115","author":"Bolton","year":"2020","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.modpat.2022.100005_bib46","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1002619","article-title":"The role of mast cells in the defence against pathogens","volume":"8","author":"Urb","year":"2012","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.modpat.2022.100005_bib47","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1136\/gut.45.2.210","article-title":"Strictures in Crohn\u2019s disease are characterised by an accumulation of mast cells colocalised with laminin but not with fibronectin or vitronectin","volume":"45","author":"Gelbmann","year":"1999","journal-title":"Gut"},{"key":"10.1016\/j.modpat.2022.100005_bib48","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1093\/ibd\/izaa125","article-title":"Mast cell tryptase promotes inflammatory bowel disease-induced intestinal fibrosis","volume":"27","author":"Liu","year":"2021","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.modpat.2022.100005_bib49","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.clim.2008.08.027","article-title":"Hyperexpression of NOD2 in intestinal mast cells of Crohn\u2019s disease patients: preferential expression of inflammatory cell-recruiting molecules via NOD2 in mast cells","volume":"130","author":"Okumura","year":"2009","journal-title":"Clin Immunol"},{"key":"10.1016\/j.modpat.2022.100005_bib50","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.coph.2015.11.005","article-title":"Mast cells and inflammatory bowel disease","volume":"25","author":"Boeckxstaens","year":"2015","journal-title":"Curr Opin Pharmacol"},{"key":"10.1016\/j.modpat.2022.100005_bib51","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1136\/gutjnl-2012-304066","article-title":"Functional bowel symptoms in quiescent inflammatory bowel diseases: role of epithelial barrier disruption and low-grade inflammation","volume":"63","author":"Vivinus-N\u00e9bot","year":"2014","journal-title":"Gut"},{"key":"10.1016\/j.modpat.2022.100005_bib52","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1097\/MCG.0000000000001394","article-title":"Quantitative analysis of intramucosal mast cells in irritable bowel syndrome: a comparison with inflammatory bowel disease in remission","volume":"55","author":"Fan","year":"2021","journal-title":"J\u00a0Clin Gastroenterol"}],"container-title":["Modern Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0893395222000059?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0893395222000059?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T20:13:20Z","timestamp":1760213600000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0893395222000059"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2]]},"references-count":52,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,2]]}},"alternative-id":["S0893395222000059"],"URL":"https:\/\/doi.org\/10.1016\/j.modpat.2022.100005","relation":{},"ISSN":["0893-3952"],"issn-type":[{"value":"0893-3952","type":"print"}],"subject":[],"published":{"date-parts":[[2023,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"What Is the Value of Counting Mast Cells in Gastrointestinal Mucosal Biopsies?","name":"articletitle","label":"Article Title"},{"value":"Modern Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.modpat.2022.100005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 United States & Canadian Academy of Pathology. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"100005"}}